Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Anteris Bio
Although SRF813 isn’t likely to reach the clinic until 2021, GSK likes cell therapy’s monotherapy and combination potential. Lilly bids $880m to acquire neurodegenerative cell therapy firm Prevail.
- Other Names / Subsidiaries
- Aditum Bio